A. Tammimäki

发表

Determination of steroids and their intact glucuronide conjugates in mouse brain by capillary liquid chromatography-tandem mass spectrometry.

R. Kostiainen, R. Ketola, S. Jäntti, 2010, Analytical chemistry.

Are genetic variants of COMT associated with addiction?

P. Männistö, A. Tammimäki, P. Männistö, 2010, Pharmacogenetics and genomics.

Roles of forced nicotine exposure and Comt gene disruption in the development of addiction-related behavioural and neurochemical changes in mice

A. Tammimäki, 2008 .

Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice

M. Karayiorgou, J. Gogos, P. Männistö, 2010, Journal of neurochemistry.

Nicotine exposure throughout early development promotes nicotine self-administration in adolescent mice and induces long-lasting behavioural changes.

O. Salminen, E. Zvartau, A. Tammimäki, 2010, European journal of pharmacology.

Unpredictable rotational responses to L-dopa in the rat model of Parkinson's disease: the role of L-dopa pharmacokinetics and striatal dopamine depletion.

M. Forsberg, A. Tammimäki, M. Käenmäki, 2012, Basic & clinical pharmacology & toxicology.

Catechol-O-methyltransferase gene polymorphism and chronic human pain: a systematic review and meta-analysis

A. Tammimäki, P. Männistö, 2012, Pharmacogenetics and genomics.

Effect of forced chronic oral nicotine exposure on intravenous self-administration and rewarding properties of acute nicotine.

E. Zvartau, A. Tammimäki, L. Ahtee, 2008, European journal of pharmacology.

Delayed O-methylation of l-DOPA in MB-COMT-deficient mice after oral administration of l-DOPA and carbidopa

A. Tammimäki, A. Aonurm-Helm, P. Männistö, 2018, Xenobiotica; the fate of foreign compounds in biological systems.

Effect of genetic modifications in the synaptic dopamine clearance systems on addiction-like behaviour in mice.

A. Tammimäki, P. Männistö, 2011, Basic & clinical pharmacology & toxicology.

Discovery of neurosteroid glucuronides in mouse brain.

R. Kostiainen, R. Ketola, A. Tammimäki, 2009, Analytica chimica acta.

Impact of human D398N single nucleotide polymorphism on intracellular calcium response mediated by α3β4α5 nicotinic acetylcholine receptors

J. Stitzel, G. Akk, A. Tammimäki, 2012, Neuropharmacology.

Increase in free choice oral ethanol self-administration in catechol-o-methyltransferase gene-disrupted male mice.

M. Karayiorgou, J. Gogos, M. Forsberg, 2008, Basic & clinical pharmacology & toxicology.

Effect of quinpirole on striatal dopamine release and locomotor activity in nicotine-treated mice.

K. Pietilä, A. Tammimäki, Helena Raattamaa, 2006, European journal of pharmacology.

Effect of S-COMT deficiency on behavior and extracellular brain dopamine concentrations in mice

H. Rauvala, A. Tammimäki, N. Kulesskaya, 2010, Psychopharmacology.

Recent advances in gene manipulation and nicotinic acetylcholine receptor biology.

J. Stitzel, A. Tammimäki, William J. Horton, 2011, Biochemical pharmacology.

Prolyl Oligopeptidase Regulates Dopamine Transporter Phosphorylation in the Nigrostriatal Pathway of Mouse

A. Tammimäki, T. Myöhänen, T. Piepponen, 2016, Molecular Neurobiology.

Importance of membrane‐bound catechol‐O‐methyltransferase in L‐DOPA metabolism: a pharmacokinetic study in two types of Comt gene modified mice

M. Karayiorgou, A. Tammimäki, J. Garcia-horsman, 2009, British journal of pharmacology.

Delayed O-methylation of l-DOPA in MB-COMT-deficient mice after oral administration of l-DOPA and carbidopa

A. Tammimäki, A. Aonurm-Helm, P. Männistö, 2018, Xenobiotica; the fate of foreign compounds in biological systems.

Generation of membrane-bound catechol-O-methyl transferase deficient mice with disctinct sex dependent behavioral phenotype.

M. Poutanen, A. Tammimäki, A. Tammimaki, 2016, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.